ANTIVIRAL TECHNOLOGIES, INC. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e7065f14-f8b6-4b83-9287-21d7ca85d4b3/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-3.0M | 2007-09-13 – 2014-09-30 | evidence 0001137050-14-000264 |
| FY 2013 | $-2.8M | 2007-09-13 – 2014-03-31 | evidence 0001137050-14-000100 |
| FY 2012 | $-2.4M | 2007-09-13 – 2013-03-31 | evidence 0001137050-13-000156 |
| FY 2011 | $-2.0M | 2007-09-13 – 2012-03-31 | evidence 0001137050-12-000165 |
| FY 2010 | $-441.3k | 2010-01-01 – 2010-12-31 | evidence 0001137050-12-000089 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).